Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Paolo Confino

For Flagship, Moderna’s COVID-19 vaccine is a tough act to follow

Noubar Afeyan, co-founder and chairman of Moderna and founder and chief executive officer of Flagship Pioneering. (Credit: Graham Hughes—Bloomberg/Getty Images)

Flagship Pioneering’s offices sit right on the water in the Kendall Square neighborhood of Cambridge, Mass., with floor-to-ceiling windows overlooking a breathtaking view of the Charles River as it gives way to Boston’s downtown skyscrapers. On a sunny spring day, the view from here can make the misery of a Bostonian winter feel worthwhile. 

For many of the folks working behind these windows, history can be divided into two parts: Life Before Moderna and Life After. Flagship Pioneering is the biotech venture capital firm best-known for funding Moderna, a startup that went from also-ran to household name after it created a highly effective COVID-19 vaccine based on its mRNA technology. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.